Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Telaprevir (VX-950), was marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors. Specifically, telaprevir inhibits the hepatitis C viral enzyme NS3/4A serine…
Research & Standards
Explore the main themes, entities and connections around Telaprevir. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
hepatitis svr therapy ribavirin patients treatment genotype incivek drug vertex viral fda drugs trial peginterferon response antiviral use standard protease
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Telaprevir | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Telaprevir | AHFS/Drugs.com | Consumer Drug Information | 1.00 | infobox |
| Telaprevir | ATC code | J05AP02 (WHO) | 1.00 | infobox |
| Telaprevir | CAS Number | 402957-28-2 N | 1.00 | infobox |
| Telaprevir | ChEBI | CHEBI:68595 N | 1.00 | infobox |
| Telaprevir | ChEMBL | ChEMBL231813 Y | 1.00 | infobox |
| Telaprevir | ChemSpider | 2279948 Y | 1.00 | infobox |
| Telaprevir | CompTox Dashboard (EPA) | DTXSID40193304 | 1.00 | infobox |
| Telaprevir | DrugBank | DB05521 N | 1.00 | infobox |
| Telaprevir | ECHA InfoCard | 100.129.857 | 1.00 | infobox |
| Telaprevir | Elimination half-life | 9–11 hours | 1.00 | infobox |
| Telaprevir | Excretion | 90% (bile), 9% (exhaled air), 1% (urine) | 1.00 | infobox |
| Telaprevir | Formula | C36H53N7O6 | 1.00 | infobox |
| Telaprevir | IUPHAR/BPS | 7871 | 1.00 | infobox |
| Telaprevir | KEGG | D09012 Y | 1.00 | infobox |
| Telaprevir | Legal status | US: ℞-only | 1.00 | infobox |
| Telaprevir | License data | US FDA: Telaprevir | 1.00 | infobox |
| Telaprevir | MedlinePlus | a611038 | 1.00 | infobox |
| Telaprevir | Metabolism | extensive hepatic | 1.00 | infobox |
| Telaprevir | Molar mass | 679.863 g·mol−1 | 1.00 | infobox |
| Telaprevir | NIAID ChemDB | 213006 | 1.00 | infobox |
| Telaprevir | Protein binding | 59–76% | 1.00 | infobox |
| Telaprevir | PubChem CID | 3010818 | 1.00 | infobox |
| Telaprevir | Routes of administration | Oral | 1.00 | infobox |
| Telaprevir | Trade names | Incivek, Incivo | 1.00 | infobox |
| Telaprevir | UNII | 655M5O3W0U | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.